Belgium and the EIB

Four companies from Belgium get together in a local, circular economy project using byproducts of steelmaking to create a masonry block that cuts carbon dioxide emissions

We have worked in Belgium since 1962, financing education and key infrastructure, such as the national railway, Antwerp's port, clean water, renewable energy and digital connectivity. We supported the installation of dozens of wind turbines off the country's coast, providing electricity to over one million households. We financed a state-of-the-art health campus in Leuven, a major initiative in line with European policies for health, education and innovation. We also supported Belgian entrepreneurs and innovators in the medtech and biotech fields. In times of crisis, we stepped up our efforts to provide relief funds to the Walloon region for flood resilience projects and social housing.  Find out more about our activities in Belgium.

Buckle up and discover a normal day in Europe through different projects financed by the European Investment Bank. Will you recognise some of them? The journey begins now! 

Cities and regions across Europe slash costs and emissions with energy efficiency investments

Wastewater is not a problem. It is a highly valuable source of water, nutrients and energy. But more than 80% of all wastewater is wasted. We need to change how we treat it and make wastewater resource recovery a priority

We have worked with Belgium since 1959. Between 2015 and 2020, we have supplied 1 345 518 households with green energy and improved health services for 6 246 000 citizens.

Belgian company helps people with disabilities develop their talents and play a bigger role in society

More partnerships and investment are needed to improve low levels of developing world vaccinations and fight future diseases. Here’s how the EU bank is working to create vaccine-manufacturing facilities in Africa and to vaccinate other regions of the world

The European Investment Bank supports iSTAR Medical, a Belgian medtech company developing a novel ophthalmic implant for patients suffering from glaucoma, the leading cause of irreversible blindness in the world. The unique device is expected to set new medical standards in the fight against the disease. Read more in the press release.

An Africa COVID vaccine production plant in Senegal is part of a plan to boost regional healthcare and to make the continent less reliant on imported vaccines